Dear Doctors: At age 51, I was diagnosed with severe rheumatic mitral stenosis. After a second round of tests, treatment was changed from open-heart surgery to balloon valvuloplasty. What can I do to ...

Q At age 51, I was diagnosed with severe rheumatic mitral stenosis. After a second round of tests, treatment was changed from open-heart surgery to balloon valvuloplasty. What can I do to help the ...

UC Irvine and Jefferson Health investigators identify distinct structural and blood-flow signatures in two major forms of mitral stenosis. Findings highlight limitations of applying rheumatic-based ...

University of California, Irvine and Philadelphia-based Jefferson Health researchers have identified fundamental structural and functional differences between two major causes of mitral valve stenosis ...

DEAR DOCTORS: At age 51, I was diagnosed with severe rheumatic mitral stenosis. After a second round of tests, treatment was changed from open-heart surgery to balloon valvuloplasty. What can I do to ...

Dear Doctors: At age 51, I was diagnosed with severe rheumatic mitral stenosis. After a second round of tests, treatment was changed from open-heart surgery to balloon valvuloplasty. What can I do to ...

Multivalvular disease (MVD) is a prevalent form of valvular heart disease; rheumatic heart disease is the predominant aetiology in developing countries, whereas degenerative aetiologies are ...

Percutaneous mitral valvuloplasty is an effective treatment in mitral stenosis. Both the short and midterm results are comparable to surgical commissurotomy. The decision to perform valvuloplasty or ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Khon Kaen, Thailand - Anticoagulation for six months dissolves left atrial clots in about one quarter of patients with severe mitral stenosis, enabling them to undergo a less invasive percutaneous ...

Advances in our understanding of the mechanisms underlying valvular heart diseases, together with technological innovations and accumulating clinical experience, have led to great improvements in the ...